Pharmacokinetics of the iron chelator desferrioxamine as affected by liposome encapsulation: Potential in treatment of chronic hemosiderosis
Authors:
- 1 January 1978
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 22 (4) , 313-320
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- The effect of particle size and charge on the clearance rates of liposomes and liposome encapsulated drugsBiochemical and Biophysical Research Communications, 1975
- Liposomes containing chelating agents. Cellular penetration and a possible mechanism of metal removal.Journal of Cell Biology, 1975
- Membrane fusion and molecular segregation in phospholipid vesiclesBiochimica et Biophysica Acta (BBA) - Biomembranes, 1974
- LONG‐TERM DESFERRIOXAMINE THERAPY IN THALASSEMIAAnnals of the New York Academy of Sciences, 1974
- Intracellular Plutonium: Removal by Liposome-Encapsulated Chelating AgentScience, 1973
- The Distribution Pattern of Radioactive Ferrioxamine Administered Intravenously in RatsActa Haematologica, 1972
- Distribution and renal excretion of desferrioxamine and ferrioxamine in the dog and in the ratBiochemical Pharmacology, 1966